Company Profile

Broad & Great Enterprise is a CDMO company specializing in the R&D and manufacturing of chemical and biopharmaceutical drugs, strategically positioned around "one production base and two R&D platforms." The company is committed to building both an innovation chain and an industry-wide value chain. With R&D innovation as its core driving force, its focus lies on small-molecule chemical drugs and biotechnology. By adopting an integrated "API and Formulation" model, leveraging an "innovative small-molecule API technology platform," and pursuing a strategy that blends generic and innovative drug development, the company has crafted a robust product pipeline. This approach enables it to secure medium- to long-term competitiveness through a continuous cycle of "developing one generation, producing another, stockpiling a third, and optimizing a fourth." Additionally, the company has established a dedicated sales and marketing team and forged long-term partnerships with over 100 GSP and CSO companies nationwide, ensuring effective drug promotion and commercialization.